Opko Health CEO Buys $431,616 in Stock (OPK)
Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 51,200 shares of Opko Health stock on the open market in a transaction that occurred on Thursday, January 2nd. The shares were purchased at an average price of $8.43 per share, for a total transaction of $431,616.00. Following the acquisition, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $16,754,625. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Opko Health (NYSE:OPK) traded up 1.66% during mid-day trading on Friday, hitting $8.55. 905,661 shares of the company’s stock traded hands. Opko Health has a 52-week low of $5.02 and a 52-week high of $12.95. The stock has a 50-day moving average of $9.70 and a 200-day moving average of $8.9. The company’s market cap is $3.488 billion.
A number of analysts have recently weighed in on OPK shares. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note to investors on Friday, December 20th. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note to investors on Wednesday, December 18th. Finally, analysts at Jefferies Group raised their price target on shares of Opko Health from $10.00 to $11.50 in a research note to investors on Wednesday, November 13th. They now have a “buy” rating on the stock.
OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.